Coronary Arteriosclerosis
|
0.600 |
Biomarker
|
disease |
CTD_human |
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.
|
11500196 |
2001 |
Coronary Arteriosclerosis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
In this respect, increased expression of MCP-1 and the corresponding receptor CCR2 have been demonstrated in renal transplant rejection and coronary artery disease.
|
12239249 |
2002 |
Coronary Arteriosclerosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Currently, there is conflicting evidence regarding an association between polymorphisms in CCR2/MCP-1 and CCR5/RANTES and coronary artery disease.
|
15017357 |
2004 |
Coronary Arteriosclerosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Lack of association between the -2518G/A polymorphism of the MCP-1 gene and ischaemic heart disease: a family-based investigation.
|
15245376 |
2004 |
Coronary Arteriosclerosis
|
0.600 |
Biomarker
|
disease |
RGD |
Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion.
|
16297799 |
2005 |
Coronary Arteriosclerosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
This study demonstrates for the first time that the MCP-1 gene -2578A>G polymorphism is associated with an excess risk of coronary atherosclerosis in an asymptomatic population and demonstrates an apparent interaction with CAD risk factor burden.
|
16934270 |
2007 |
Coronary Arteriosclerosis
|
0.600 |
Biomarker
|
disease |
CTD_human |
This study demonstrates for the first time that the MCP-1 gene -2578A>G polymorphism is associated with an excess risk of coronary atherosclerosis in an asymptomatic population and demonstrates an apparent interaction with CAD risk factor burden.
|
16934270 |
2007 |
Coronary Arteriosclerosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease.
|
19247801 |
2010 |
Coronary Arteriosclerosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population.
|
19332042 |
2009 |
Coronary Arteriosclerosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Epicardial fat was clearly different from substernal fat because there was a far higher expression of haptoglobin, prostaglandin D(2) synthase, nerve growth factor beta, the soluble vascular endothelial growth factor receptor (FLT1), and alpha1 glycoprotein but not of inflammatory adipokines such as monocyte chemoattractant protein-1, interleukin (IL)-8, IL-1beta, tumor necrosis factor alpha, serum amyloid A, plasminogen activator inhibitor-1, or adiponectin despite underlying coronary atherosclerosis.
|
20116810 |
2010 |
Coronary Arteriosclerosis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease.
|
20431065 |
2010 |
Coronary Arteriosclerosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: a meta-analysis.
|
21868018 |
2011 |
Coronary Arteriosclerosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility.
|
22752804 |
2012 |
Coronary Arteriosclerosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Association of -2518A>G promoter polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with type 2 diabetes and coronary artery disease.
|
23930970 |
2013 |
Coronary Arteriosclerosis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Serum levels of monocyte chemoattractant protein-1 and all-cause and cardiovascular mortality among patients with coronary artery disease.
|
25786118 |
2015 |
Coronary Arteriosclerosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Association of monocyte chemoattractant protein-1 (MCP-1)-2518A>G polymorphism with susceptibility to coronary artery disease: a meta-analysis.
|
25875728 |
2015 |
Coronary Arteriosclerosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography.
|
28534120 |
2017 |
Coronary Arteriosclerosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females.
|
30557342 |
2018 |
Coronary Arteriosclerosis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Genetically determined higher MCP-1 levels were further associated with coronary artery disease (OR, 1.04; 95% CI, 1.00-1.08; P=0.04) and myocardial infarction (OR, 1.05; 95% CI, 1.01-1.09; P=0.02), but not with atrial fibrillation.
|
30586705 |
2019 |
Coronary Arteriosclerosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Recent studies have indicated that monocyte chemoattractant protein-1 (MCP-1) plays an important role in the initiation and progression of ischaemic heart disease.
|
31077149 |
2019 |
Coronary Arteriosclerosis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Regulatory Factor X1 Downregulation Contributes to Monocyte Chemoattractant Protein-1 Overexpression in CD14+ Monocytes <i>via</i> Epigenetic Mechanisms in Coronary Heart Disease.
|
31737059 |
2019 |
Coronary Arteriosclerosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
In a necropsy study, we used immunohistochemistry to explore where and to what extent CCL2 and related receptors are present in diseased arteries that caused the death of men with coronary artery disease compared with unaffected arteries.
|
31739217 |
2020 |
Coronary Arteriosclerosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF-κB, and MCP-1 in patients with coronary artery disease: A randomized placebo-controlled clinical trial.
|
31797473 |
2019 |